e 64 has been researched along with Lung Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Golouh, R; Jeras, M; Kos, J; Langerholc, T; Premzl, A; Repnik, U; Sekirnik, A; Turk, B; Turk, V; Werle, B; Zavasnik Bergant, V | 1 |
| Ebert, W; Jülke, B; Lah, T; Spiess, E; Werle, B | 1 |
| Jani, JP; Lazo, JS; Mistry, JS; Morris, G; Sebti, SM | 1 |
3 other study(ies) available for e 64 and Lung Neoplasms
| Article | Year |
|---|---|
Carboxypeptidases cathepsins X and B display distinct protein profile in human cells and tissues.
Topics: Antibodies, Monoclonal; Antibody Specificity; Carboxypeptidases; Cathepsin B; Cathepsin K; Cathepsins; Cell Line, Tumor; Cell Movement; Collagen; Cysteine Proteinase Inhibitors; Cytosol; Dendritic Cells; Drug Combinations; Flow Cytometry; Humans; Immunohistochemistry; Laminin; Leucine; Lung; Lung Neoplasms; Lymph Nodes; Monocytes; Neoplasm Invasiveness; Proteoglycans; U937 Cells | 2005 |
Cathepsin B fraction active at physiological pH of 7.5 is of prognostic significance in squamous cell carcinoma of human lung.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cathepsin B; Cysteine Proteinase Inhibitors; Dipeptides; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Leucine; Lung; Lung Neoplasms; Middle Aged; Prognosis; Substrate Specificity; Survival Analysis | 1997 |
In vivo sensitization of human lung carcinoma to bleomycin by the cysteine proteinase inhibitor E-64.
Topics: Animals; Bleomycin; Cell Line; Cysteine Proteinase Inhibitors; Drug Administration Schedule; Drug Resistance; Female; Humans; Leucine; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Time Factors; Transplantation, Heterologous; Tumor Cells, Cultured | 1992 |